Patent: 5,457,093
✉ Email this page to a colleague
Summary for Patent: 5,457,093
Title: | Gel formulations containing growth factors |
Abstract: | Gel formulations containing polypeptide growth factors having human mitogenic or angiogenic activity are provided. The gel formulations are useful for topical or incisional wound healing for cutaneous wounds, in the anterior chamber of the eye and other ophthalmic wound healing. The gel formulations also comprise a water soluble, pharmaceutically or ophthalmically compatible polymeric material for providing viscosity within various ranges determined by the application of the gel. The gel formulations provide controlled release and increased contact time of the growth factor to the wound site. |
Inventor(s): | Cini; John K. (Bethlehem, PA), Finkenaur; Amy L. (Neshanic Station, NJ) |
Assignee: | Ethicon, Inc. (Somerville, NJ) |
Application Number: | 08/135,230 |
Patent Claims: | see list of patent claims |
Details for Patent 5,457,093
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | REGRANEX | becaplermin | Gel | 103691 | December 16, 1997 | ⤷ Sign Up | 2012-10-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,457,093
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E209900 | ⤷ Sign Up |
Australia | 2223588 | ⤷ Sign Up |
Australia | 706806 | ⤷ Sign Up |
Australia | 7370796 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |